NIH Exploratory/Developmental Research Project Grant (Parent R21, Clinical Trial Not Allowed) PA-25-304 – February 2027 due date
The NIH Exploratory/Developmental Research Project Grant (Parent R21, Clinical Trial Not Allowed), PA-25-304, supports exploratory or developmental research within the mission of participating NIH institutes; this guide focuses on the 16 February 2027 due date. It covers research areas consistent with the scheme, eligibility and readiness checks, what review panels typically value and how to plan an application.
The published deadline has passed. Check the official page in case it has been extended, or browse the open listings.
Key dates
- Application deadline
- 16 February 2027
- Details last checked
- 10 November 2026
About the call
- Funder
- National Institutes of Health
- Country
- United States
- Scheme type
- Project grant
- Funding
- As stated in the call documents
- Eligibility
- Exploratory or developmental research projects within the mission of participating NIH institutes; applications proposing clinical trials are not accepted.
- Scope
- Medicine and clinical research
Topics consistent with the call
- Development of new research methods, assays or technologies
- Pilot and feasibility studies that establish proof of concept
- Exploratory mechanistic studies in disease biology
- Observational studies that generate preliminary data for larger projects
- Secondary analyses of existing datasets addressing novel questions
Based on the published scope; the official page sets out the full themes and requirements.
Is your work a fit? Check before you apply
- Confirm that the project is exploratory or developmental and does not propose a clinical trial.
- Check that the topic falls within the mission of a participating NIH institute or centre.
- Review institute-specific requirements and budget and duration limits in PA-25-304.
- Ensure your institution is registered and ready to submit through the required systems.
- Prepare a complete, institutionally approved application before 16 February 2027.
Why This Funding Call Matters
New research directions often need early-stage support before they can compete for larger awards. The parent R21 is designed for exploratory and developmental projects that may involve considerable risk but could lead to a breakthrough or to new methods, models or applications. For investigators, it provides a route to test a novel idea and gather the preliminary data that later applications usually require. Because clinical trials are not allowed under this announcement, it suits laboratory, observational and methodological work.
Who Should Apply
Academic backgrounds
- Biomedical sciences
- Epidemiology
- Bioengineering
- Behavioural and social sciences
- Bioinformatics
Institutions and sectors
- Universities and medical schools
- Independent research institutes
- Hospitals and academic medical centres
- Other organisations eligible under NIH rules
What Reviewers Typically Value
- A novel idea with potential to open a new research direction.
- A clear rationale for why an exploratory approach is appropriate.
- A feasible plan with milestones that can be achieved within the award period.
- Strong potential for the results to support future, larger research projects.
Ideas You Could Develop
Your Plan to the Deadline
A suggested schedule working back from 16 February 2027. Adjust it to the stage your work has reached.
By 22 Dec 2026
Read the call documents; confirm eligibility, budget limits, assessment criteria and institutional requirements.
By 5 Jan 2027
Agree the research question, aims, team and partners; contact your research office.
By 19 Jan 2027
Draft the case for support, methods, impact and budget.
By 2 Feb 2027
Obtain internal review, letters of support and institutional sign-off.
By 11 Feb 2027
Final checks against the funder’s guidance and formatting rules.
By 16 Feb 2027
Submit through the funder’s system before the deadline.
What you gain
- Funding for the research, team and resources it needs.
- Recognition from a competitive, peer-reviewed process.
- Reviewer feedback that strengthens future applications.
- A track record for larger grants and fellowships.
What happens after you apply
- Eligibility check: the funder confirms the application meets the call rules.
- Peer review: external reviewers assess the proposal against the published criteria.
- Panel: a committee ranks proposals; some schemes include an interview.
- Decision: outcomes are released on the funder’s timetable.
- Award: successful applicants agree terms and reporting requirements before starting.
What the Funder Are Looking For
The NIH is looking for exploratory or developmental projects within the mission of participating institutes that could establish new research directions, methods or models. Applications that present an innovative idea, a clear rationale and a feasible plan are likely to be competitive, provided they do not propose a clinical trial. Participating institutes, budget limits, eligibility and submission instructions should be confirmed in the PA-25-304 notice of funding opportunity.
Expert help
How Pubrica Can Help
Pubrica’s subject specialists can help you prepare a competitive proposal, planned back from the deadline. You remain the author of your work.
FAQs
Questions Researchers Ask
The next published deadline is 16 February 2027. Dates can change, so confirm them on the official page before you plan your work.
Studies with human participants may be possible under this announcement if they do not meet the NIH definition of a clinical trial. Applicants should check the NIH clinical trial definition and the PA-25-304 notice, and consult programme staff at the relevant institute if uncertain.
Exploratory or developmental research projects within the mission of participating NIH institutes; applications proposing clinical trials are not accepted. Confirm the full eligibility rules in the call documents.
Yes. Pubrica’s specialists can review, write, edit and format your proposal. You remain the author and the person responsible for the submission.
Sources
- National Institutes of Health. (2026). NIH Exploratory/Developmental Research Project Grant (Parent R21, Clinical Trial Not Allowed) PA-25-304 – February 2027 due date. Retrieved 10 November 2026, from https://grants.nih.gov/grants/guide/pa-files/PA-25-304.html
How to cite this page
Pubrica Insights. (2026). NIH Exploratory/Developmental Research Project Grant (Parent R21, Clinical Trial Not Allowed) PA-25-304 – February 2027 due date. Pubrica. https://pubrica.com/insights/calls-and-conferences/nih-exploratory-developmental-research-project-grant-parent-r21-clinic/
Pubrica Insights. “NIH Exploratory/Developmental Research Project Grant (Parent R21, Clinical Trial Not Allowed) PA-25-304 – February 2027 due date.” Pubrica, 2026, https://pubrica.com/insights/calls-and-conferences/nih-exploratory-developmental-research-project-grant-parent-r21-clinic/.
Pubrica Insights (2026) NIH Exploratory/Developmental Research Project Grant (Parent R21, Clinical Trial Not Allowed) PA-25-304 – February 2027 due date. Pubrica. Available at: https://pubrica.com/insights/calls-and-conferences/nih-exploratory-developmental-research-project-grant-parent-r21-clinic/ (Accessed: 10 November 2026).
Pubrica Insights. NIH Exploratory/Developmental Research Project Grant (Parent R21, Clinical Trial Not Allowed) PA-25-304 – February 2027 due date [Internet]. Pubrica; 2026 [cited 2026 Nov 10]. Available from: https://pubrica.com/insights/calls-and-conferences/nih-exploratory-developmental-research-project-grant-parent-r21-clinic/
Funding call